Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Clin Oncol. Jan 24, 2024; 15(1): 89-114
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.89
Table 1 Primers for disulfidptosis-related lncRNAs/Genes
LncRNA/Gene
Forward primer
Reverse primer
AC005034.5TGCAAGGTGTCATCTGTAAGGTGACAGTTCCAACAGGGCTA
AC011815.1GGCCAGCGACAGATCCTTTTGGCCCACTGTTGCCATCAA
AC013652.1AGGGCATCAGACTGCATTTCAGACAAGCAGAAAATGGGGCA
AC093157.1GAGATGGGCAAGCCTACACCTGGGTCCAGAAAGAAGTTGC
AL354993.2TGCATTCCAGAGGGAGGAGACCACTCCTTGGAAGCTGTCT
AL683813.1GCGGCTGAGTTTCTGACTCTGTTTGGGATACAGGAGGCCG
TNFRSF10A-AS1TCAGTGATAGCAACAGAAAACAGACTGCACCTAGCCAAGATGTC
TCAPGAGTTCCCAAAGGGAGGGTGTTTTCCTGGATCAGGGCCAC
NNATAATCAAAACACCGCACCAGCACCACCCTCCTTCCTCAACT
CHGBGGTCCTCTCAAGGAGGGAGTAGTGGGTTGAATGGTGGTCC
COL2A1GCTCCCAGAACATCACCTACCCGATAACAGTCTTGCCCCAC
β-actinCGCGAGAAGATGCCCAGATCTCACCGGAGTCCATCACGA
Table 2 Clinical characteristics of colorectal cancer patients in the training and testing groups, n (%)
Covariates
Type
Total
Test
Train
P value
Age≤ 70312 (57.56)160 (59.04)152 (56.09)0.543
Age> 70230 (42.44)111 (40.96)119 (43.91)-
GenderFEMALE255 (47.05)137 (50.55)118 (43.54)0.1214
GenderMALE287 (52.95)134 (49.45)153 (56.46)-
StageStageI93 (17.16)43 (15.87)50 (18.45)0.3949
StageStageII208 (38.38)100 (36.9)108 (39.85)-
StageStageIII148 (27.31)82 (30.26)66 (24.35)-
StageStageIV78 (14.39)36 (13.28)42 (15.5)-
StageUnknow15 (2.77)10 (3.69)5 (1.85)-
TT115 (2.77)6 (2.21)9 (3.32)0.8475
TT293 (17.16)45 (16.61)48 (17.71)-
TT3370 (68.27)188 (69.37)182 (67.16)-
TT463 (11.62)32 (11.81)31 (11.44)-
TUnknow1 (0.18)0 (0)1 (0.37)-
MM0402 (74.17)205 (75.65)197 (72.69)0.4435
MM177 (14.21)35 (12.92)42 (15.5)-
MUnknow63 (11.62)31 (11.44)32 (11.81)-
NN0318(58.67)154 (56.83)164 (60.52)0.5238
NN1129 (23.8)70 (25.83)59 (21.77)-
NN294 (17.34)46 (16.97)48 (17.71)-
NUnknow1 (0.18)1 (0.37)0 (0)-